查看購物車
  • Simplified Chinese
  • English
2021-2031年北美客製化抗體服務市場報告：範圍、細分、動態和競爭分析
市場調查報告書
商品編碼
1871504

2021-2031年北美客製化抗體服務市場報告：範圍、細分、動態和競爭分析

North America Custom Antibody Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 210 Pages | 訂單完成後即時交付

價格

預計北美客製化抗體服務市場將大幅成長，到 2031 年將達到約 5.7776 億美元，高於 2023 年的 2.8749 億美元，2023 年至 2031 年的年複合成長率(CAGR) 預計為 9.1%。

執行摘要和市場分析

北美客製化抗體服務市場主要分為美國、加拿大和墨西哥三大區域。推動該市場成長的因素眾多，包括先進技術的日益普及、藥物研發投入的不斷增加、政府對臨床研究的大力支持以及臨床診斷研究活動的蓬勃發展。此外，政府機構與市場參與者之間的合作也促進了客製化抗體在臨床診斷中的應用。美國和加拿大癌症及基因組研究計畫的不斷湧現，以及對抗體療法研發的重視，也推動了市場擴張。對高品質研究工具的需求，以確保資料可重複性，進一步促進了北美客製化抗體服務市場的成長。

市場區隔分析

北美客製化抗體服務市場可根據產品類型、服務類型、應用、疾病適應症、來源和最終用戶進行細分：

  • 產品類型：市場可分為單株抗體、多株抗體、雜交瘤抗體、重組抗體及其他抗體。 2023年，單株抗體佔最大的市佔率。
  • 服務類型：此細分市場包括抗體發現和開發、抗體生產服務等，其中抗體發現和開發在 2023 年的市場佔有率中領先。
  • 應用領域：應用包括免疫組織化學、蛋白質印跡和免疫沉澱（IP）、酵素連結免疫吸附試驗（ELISA）、螢光活化細胞分選、質譜分析等。其中，ELISA是2023年最重要的應用。
  • 疾病適應症：市場分為腫瘤學、傳染病學、免疫學、心血管疾病和其他領域，其中腫瘤學是 2023 年最大的細分市場。
  • 資料來源：這包括雞、兔、大鼠、豚鼠和小鼠或人源化小鼠，其中後者在 2023 年佔據最大佔有率。此部分進一步細分為單株抗體和其他技術的各種平台。
  • 最終用戶：最終用戶包括生命科學產業、製藥和生物技術公司、學術和研究機構以及合約研究組織，其中生命科學產業在 2023 年的市佔率領先。

市場展望

FDA在批准生物相似藥方面發揮著至關重要的作用，生物相似藥的核准通過提供更多藥物選擇並可能降低成本，從而改善患者護理。近期獲準的生物相似藥，例如Alymsys和Cimerli，大大拓展了治療選擇。 FDA批准的生物相似藥數量不斷增加，預計將推動客製化抗體服務市場的成長，因為它們可以降低治療成本並提高生物療法的可及性。

國家概況

北美客製化抗體服務市場主要由美國驅動，美國在2023年佔據最大市場佔有率。美國傳染病、慢性病和自體免疫疾病發生率的上升，推動了對客製化抗體服務的需求成長。癌症仍是主要的死亡原因之一，2022年新增病例超過190萬例，預計2024年新增病例將達到約200萬例。客製化抗體在癌症治療中至關重要，可用於檢測腫瘤特異性抗原和監測患者病情進展。美國市場受益於研發投入的增加以及客製化抗體在包括腫瘤學和免疫學在內的各個研究領域中日益廣泛的應用。

公司簡介

客製化抗體服務市場的主要參與者包括 Thermo Fisher Scientific Inc.、Sino Biological Inc.、GenScript Biotech Corporation、Biochain Incorporated、R&D Systems, Inc.、Kaneka Eurogentec SA、Fortis Life Sciences、Precision Antibody、Biocytogen Pharmaceuticals、Abgenc​​an、Creative Technologieslabs、Agilc​​yas、Abgen​​ytorys、Abgenptory、Creative 地區、Agilc​​ytorys、Abgenctory.這些公司正在採用擴張、產品創新以及併購等策略來增強其市場佔有率，並為客戶提供創新解決方案。

目錄

第1章：引言

第2章：執行概要

  • 關鍵見解

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：

第4章：北美客製化抗體服務市場概況

  • 概述
  • PEST分析

第5章：北美客製化抗體服務市場－主要市場動態

  • 市場促進因素
    • 慢性病盛行率不斷上升
    • 生物相似藥核准數量不斷上升
  • 市場限制
    • 利用基因改造動物生產抗體的高成本和複雜性
  • 市場機遇
    • 新興經濟體及已開發經濟體政府研發活動增加
  • 未來趨勢
    • 利用重組抗體的技術進步
  • 駕駛員和安全帶的影響：

第6章：客製化抗體服務市場－北美分析

  • 2021-2031年北美客製化抗體服務市場收入
  • 北美客製化抗體服務市場預測分析

第7章：北美客製化抗體服務市場分析－依最終用戶分類

  • 生命科學產業
  • 製藥和生物技術公司
  • 學術和研究機構
  • 合約研究組織

第8章：北美客製化抗體服務市場分析－依疾病指徵分類

  • 腫瘤學
  • 傳染病
  • 免疫學
  • 心血管疾病
  • 其他

第9章：北美客製化抗體服務市場分析－依來源分類

  • 雞
  • 兔子
  • 老鼠
  • 天竺鼠
  • 小鼠或人源化小鼠
  • 其他

第10章：北美客製化抗體服務市場分析－以小鼠或人源化小鼠分類

  • 單株抗體平台
  • BsAb發現平台
  • 雙特異性抗體藥物偶聯平台
  • TCR模擬抗體平台
  • 抗GPCR抗體技術平台
  • 其他

第11章：北美客製化抗體服務市場分析－按應用領域分類

  • 免疫組織化學（IHC）
  • Western Blot 和免疫沉澱
  • 酵素連結免疫吸附試驗
  • 螢光活化細胞分選（FACS）
  • 質譜分析
  • 其他

第12章：北美客製化抗體服務市場分析－依服務類型分類

  • 抗體發現與開發
  • 抗體生產服務
  • 其他

第13章：北美客製化抗體服務市場分析－依產品類型分類

  • 單株抗體
  • 多株抗體雜交瘤
  • 重組抗體
  • 其他

第14章：北美客製化抗體服務市場－國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第15章：客製化抗體服務市場－產業概況

  • 概述
  • 客製化抗體服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第16章：公司簡介

  • Thermo Fisher Scientific Inc
  • Sino Biological Inc.
  • GenScript Biotech Corporation
  • Biochain Incorporated
  • R&D Systems, Inc
  • Kaneka Eurogentec S.A.
  • Fortis Life Sciences
  • Precision Antibody (A&G Pharmaceutical, Inc.)
  • Biocytogen Pharmaceuticals Beijing Co Ltd
  • Abgenex
  • Creative Biolabs Inc
  • Agilent Technologies Inc
  • Bioklone
  • Scantibodies Laboratory, Inc.

第17章：附錄

Product Code: BMIRE00032161

The North America custom antibody services market is projected to grow significantly, reaching approximately US$ 577.76 million by 2031, up from US$ 287.49 million in 2023, with an estimated compound annual growth rate (CAGR) of 9.1% from 2023 to 2031.

Executive Summary and Market Analysis

The custom antibody services market in North America is divided into three main regions: the United States, Canada, and Mexico. Several factors are driving the growth of this market, including the increasing adoption of advanced technologies, rising investments in drug discovery and development, strong government support for clinical research, and a surge in research activities in clinical diagnostics. Additionally, collaborations between government bodies and market players are promoting the use of custom antibodies in clinical diagnostics. The growing number of cancer and genomic research initiatives in the US and Canada, along with a focus on developing antibody-based therapeutics, are also contributing to market expansion. The demand for high-quality research tools to ensure data reproducibility further supports the growth of the custom antibody services market in North America.

Market Segmentation Analysis

The North America custom antibody services market can be segmented based on product type, service type, application, disease indication, source, and end user:

  • Product Type: The market is categorized into monoclonal, polyclonal, hybridoma, recombinant antibodies, and others. In 2023, monoclonal antibodies held the largest market share.
  • Service Type: This segment includes antibody discovery and development, antibody production services, and others, with antibody discovery and development leading in market share in 2023.
  • Application: The applications include immunohistochemistry, western blotting & immunoprecipitation (IP), ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. ELISA was the most significant application in 2023.
  • Disease Indication: The market is segmented into oncology, infectious diseases, immunology, cardiovascular diseases, and others, with oncology being the largest segment in 2023.
  • Source: This includes chicken, rabbits, rats, guinea pigs, and mouse or humanized mice, with the latter holding the largest share in 2023. This segment is further divided into various platforms for monoclonal antibodies and other technologies.
  • End User: The end users include the life sciences industry, pharmaceutical and biotech companies, academic and research institutes, and contract research organizations, with the life sciences industry leading in market share in 2023.

Market Outlook

The FDA plays a crucial role in approving biosimilar products, which enhances patient care by providing more medication options at potentially lower costs. Recent approvals of biosimilars, such as Alymsys and Cimerli, have been significant in expanding treatment options. The increasing number of biosimilars approved by the FDA is expected to drive the growth of the custom antibody services market, as they can lower treatment costs and improve access to biologic therapies.

Country Insights

The North American custom antibody services market is primarily driven by the US, which accounted for the largest share in 2023. The rising incidence of infectious, chronic, and autoimmune diseases in the US is increasing the demand for custom antibody services. Cancer remains a leading cause of death, with over 1.9 million new cases diagnosed in 2022, and projections suggest around 2.0 million new diagnoses in 2024. Custom antibodies are essential in cancer treatment for detecting tumor-specific antigens and monitoring patient progress. The US market benefits from increased R&D efforts and the growing use of custom antibodies across various research fields, including oncology and immunology.

Company Profiles

Key players in the custom antibody services market include Thermo Fisher Scientific Inc., Sino Biological Inc., GenScript Biotech Corporation, Biochain Incorporated, R&D Systems, Inc., Kaneka Eurogentec S.A., Fortis Life Sciences, Precision Antibody, Biocytogen Pharmaceuticals, Abgenex, Creative Biolabs, Agilent Technologies, Bioklone, and Scantibodies Laboratory, Inc. These companies are employing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their customers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Custom Antibody Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Custom Antibody Services Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Rising Approvals of Biosimilars
  • 5.2 Market Restraints
    • 5.2.1 High Costs and Complexities Associated with Antibody Production Using Transgenic Animals
  • 5.3 Market Opportunities
    • 5.3.1 Rise in Government Research and Development Activities in Emerging and Developed Economies
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements Using Recombinant Antibodies
  • 5.5 Impact of Drivers and Restraints:

6. Custom Antibody Services Market - North America Analysis

  • 6.1 North America Custom Antibody Services Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Custom Antibody Services Market Forecast Analysis

7. North America Custom Antibody Services Market Analysis - by End User

  • 7.1 Life Science Industry
    • 7.1.1 Overview
    • 7.1.2 Life Science Industry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Pharmaceutical and Biotech Companies
    • 7.2.1 Overview
    • 7.2.2 Pharmaceutical and Biotech Companies: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Academic and Research Institutes
    • 7.3.1 Overview
    • 7.3.2 Academic and Research Institutes: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Contract Research Organizations
    • 7.4.1 Overview
    • 7.4.2 Contract Research Organizations: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Custom Antibody Services Market Analysis - by Disease Indication

  • 8.1 Oncology
    • 8.1.1 Overview
    • 8.1.2 Oncology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Infectious Diseases
    • 8.2.1 Overview
    • 8.2.2 Infectious Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Immunology
    • 8.3.1 Overview
    • 8.3.2 Immunology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Cardiovascular Diseases
    • 8.4.1 Overview
    • 8.4.2 Cardiovascular Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Custom Antibody Services Market Analysis - by Source

  • 9.1 Chicken
    • 9.1.1 Overview
    • 9.1.2 Chicken: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Rabbits
    • 9.2.1 Overview
    • 9.2.2 Rabbits: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Rats
    • 9.3.1 Overview
    • 9.3.2 Rats: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.4 Guinea Pigs
    • 9.4.1 Overview
    • 9.4.2 Guinea Pigs: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.5 Mouse or Humanized Mice
    • 9.5.1 Overview
    • 9.5.2 Mouse or Humanized Mice: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Custom Antibody Services Market Analysis - by Mouse or Humanized Mice

  • 10.1 Monoclonal Antibody Platform
    • 10.1.1 Overview
    • 10.1.2 Monoclonal Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.2 BsAb Discovery Platform
    • 10.2.1 Overview
    • 10.2.2 BsAb Discovery Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.3 Bispecific ADC Platform
    • 10.3.1 Overview
    • 10.3.2 Bispecific ADC Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.4 TCR-Mimic Antibody Platform
    • 10.4.1 Overview
    • 10.4.2 TCR-Mimic Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.5 Anti-GPCR Antibody Technology Platform
    • 10.5.1 Overview
    • 10.5.2 Anti-GPCR Antibody Technology Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. North America Custom Antibody Services Market Analysis - by Application

  • 11.1 Immunohistochemistry (IHC)
    • 11.1.1 Overview
    • 11.1.2 Immunohistochemistry (IHC): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.2 Western Blot and IP
    • 11.2.1 Overview
    • 11.2.2 Western Blot and IP: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.3 ELISA
    • 11.3.1 Overview
    • 11.3.2 ELISA: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.4 Fluorescence-activated cell sorting (FACS)
    • 11.4.1 Overview
    • 11.4.2 Fluorescence-activated cell sorting (FACS): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.5 Mass Spectrometry
    • 11.5.1 Overview
    • 11.5.2 Mass Spectrometry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.6 Others
    • 11.6.1 Overview
    • 11.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. North America Custom Antibody Services Market Analysis - by Service Type

  • 12.1 Antibody Discovery and Development
    • 12.1.1 Overview
    • 12.1.2 Antibody Discovery and Development: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 12.2 Antibody Production Services
    • 12.2.1 Overview
    • 12.2.2 Antibody Production Services: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 12.3 Others
    • 12.3.1 Overview
    • 12.3.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

13. North America Custom Antibody Services Market Analysis - by Product Type

  • 13.1 Monoclonal
    • 13.1.1 Overview
    • 13.1.2 Monoclonal: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 13.2 Polyclonal hybridoma
    • 13.2.1 Overview
    • 13.2.2 Polyclonal hybridoma: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 13.3 Recombinant antibody
    • 13.3.1 Overview
    • 13.3.2 Recombinant antibody: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 13.4 Others
    • 13.4.1 Overview
    • 13.4.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

14. North America Custom Antibody Services Market - Country Analysis

  • 14.1 North America
    • 14.1.1 North America Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
      • 14.1.1.1 North America Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
      • 14.1.1.2 United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 14.1.1.2.1 United States: North America Custom Antibody Services Market Share - by End User
        • 14.1.1.2.2 United States: North America Custom Antibody Services Market Share - by Disease Indication
        • 14.1.1.2.3 United States: North America Custom Antibody Services Market Share - by Source
        • 14.1.1.2.4 United States: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
        • 14.1.1.2.5 United States: North America Custom Antibody Services Market Share - by Application
        • 14.1.1.2.6 United States: North America Custom Antibody Services Market Share - by Service Type
        • 14.1.1.2.7 United States: North America Custom Antibody Services Market Share - by Product Type
      • 14.1.1.3 Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 14.1.1.3.1 Canada: North America Custom Antibody Services Market Share - by End User
        • 14.1.1.3.2 Canada: North America Custom Antibody Services Market Share - by Disease Indication
        • 14.1.1.3.3 Canada: North America Custom Antibody Services Market Share - by Source
        • 14.1.1.3.4 Canada: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
        • 14.1.1.3.5 Canada: North America Custom Antibody Services Market Share - by Application
        • 14.1.1.3.6 Canada: North America Custom Antibody Services Market Share - by Service Type
        • 14.1.1.3.7 Canada: North America Custom Antibody Services Market Share - by Product Type
      • 14.1.1.4 Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 14.1.1.4.1 Mexico: North America Custom Antibody Services Market Share - by End User
        • 14.1.1.4.2 Mexico: North America Custom Antibody Services Market Share - by Disease Indication
        • 14.1.1.4.3 Mexico: North America Custom Antibody Services Market Share - by Source
        • 14.1.1.4.4 Mexico: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
        • 14.1.1.4.5 Mexico: North America Custom Antibody Services Market Share - by Application
        • 14.1.1.4.6 Mexico: North America Custom Antibody Services Market Share - by Service Type
        • 14.1.1.4.7 Mexico: North America Custom Antibody Services Market Share - by Product Type

15. Custom Antibody Services Market - Industry Landscape

  • 15.1 Overview
  • 15.2 Growth Strategies in Custom Antibody Services Market
  • 15.3 Organic Growth Strategies
    • 15.3.1 Overview
  • 15.4 Inorganic Growth Strategies
    • 15.4.1 Overview

16. Company Profiles

  • 16.1 Thermo Fisher Scientific Inc
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Sino Biological Inc.
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 GenScript Biotech Corporation
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Biochain Incorporated
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 R&D Systems, Inc
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 Kaneka Eurogentec S.A.
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Fortis Life Sciences
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Precision Antibody (A&G Pharmaceutical, Inc.)
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Biocytogen Pharmaceuticals Beijing Co Ltd
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments
  • 16.10 Abgenex
    • 16.10.1 Key Facts
    • 16.10.2 Business Description
    • 16.10.3 Products and Services
    • 16.10.4 Financial Overview
    • 16.10.5 SWOT Analysis
    • 16.10.6 Key Developments
  • 16.11 Creative Biolabs Inc
    • 16.11.1 Key Facts
    • 16.11.2 Business Description
    • 16.11.3 Products and Services
    • 16.11.4 Financial Overview
    • 16.11.5 SWOT Analysis
    • 16.11.6 Key Developments
  • 16.12 Agilent Technologies Inc
    • 16.12.1 Key Facts
    • 16.12.2 Business Description
    • 16.12.3 Products and Services
    • 16.12.4 Financial Overview
    • 16.12.5 SWOT Analysis
    • 16.12.6 Key Developments
  • 16.13 Bioklone
    • 16.13.1 Key Facts
    • 16.13.2 Business Description
    • 16.13.3 Products and Services
    • 16.13.4 Financial Overview
    • 16.13.5 SWOT Analysis
    • 16.13.6 Key Developments
  • 16.14 Scantibodies Laboratory, Inc.
    • 16.14.1 Key Facts
    • 16.14.2 Business Description
    • 16.14.3 Products and Services
    • 16.14.4 Financial Overview
    • 16.14.5 SWOT Analysis
    • 16.14.6 Key Developments

17. Appendix

  • 17.1 About The Insight Partners
  • 17.2 Glossary of Terms

List Of Tables

  • Table 1. North America Custom Antibody Services Market Segmentation
  • Table 2. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 4. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease Indication
  • Table 5. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Mouse Or Humanized Mice
  • Table 7. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 8. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Type
  • Table 9. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
  • Table 10. North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 11. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 12. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Indication
  • Table 13. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 14. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Mouse Or Humanized Mice
  • Table 15. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 16. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 17. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 18. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 19. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Indication
  • Table 20. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 21. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Mouse Or Humanized Mice
  • Table 22. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 23. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 24. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 25. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 26. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Indication
  • Table 27. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 28. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Mouse Or Humanized Mice
  • Table 29. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 30. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 31. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 32. Recent Organic Growth Strategies in Custom Antibody Services Market
  • Table 33. Recent Inorganic Growth Strategies in the Custom Antibody Services Market
  • Table 34. Glossary of Terms, Custom Antibody Services Market

List Of Figures

  • Figure 1. North America Custom Antibody Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Custom Antibody Services Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Custom Antibody Services Market Revenue (US$ Million), 2021-2031
  • Figure 6. North America Custom Antibody Services Market Share (%) - by End User (2023 and 2031)
  • Figure 7. Life Science Industry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Pharmaceutical and Biotech Companies: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Academic and Research Institutes: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Contract Research Organizations: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. North America Custom Antibody Services Market Share (%) - by Disease Indication (2023 and 2031)
  • Figure 12. Oncology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Infectious Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Immunology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Cardiovascular Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. North America Custom Antibody Services Market Share (%) - by Source (2023 and 2031)
  • Figure 18. Chicken: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Rabbits: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Rats: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Guinea Pigs: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Mouse or Humanized Mice: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. North America Custom Antibody Services Market Share (%) - by Mouse Or Humanized Mice (2023 and 2031)
  • Figure 25. Monoclonal Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. BsAb Discovery Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Bispecific ADC Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. TCR-Mimic Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. Anti-GPCR Antibody Technology Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. North America Custom Antibody Services Market Share (%) - by Application (2023 and 2031)
  • Figure 32. Immunohistochemistry (IHC): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Western Blot and IP: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. ELISA: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Fluorescence-activated cell sorting (FACS): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Mass Spectrometry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. North America Custom Antibody Services Market Share (%) - by Service Type (2023 and 2031)
  • Figure 39. Antibody Discovery and Development: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. Antibody Production Services: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. North America Custom Antibody Services Market Share (%) - by Product Type (2023 and 2031)
  • Figure 43. Monoclonal: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. Polyclonal hybridoma: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. Recombinant antibody: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. North America Custom Antibody Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 48. United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 49. Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 50. Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 51. Growth Strategies in Custom Antibody Services Market